Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.
Ontology highlight
ABSTRACT: Aurora B kinase is aberrantly overexpressed in various tumors and shown to be a promising target for anti-cancer therapy. In human oral squamous cell carcinoma (OSCC), the high protein level of Aurora B is required for maintaining of malignant phenotypes, including in vitro cell growth, colony formation, and in vivo tumor development. By molecular modeling screening of 74 commercially available natural products, we identified that Tanshinone IIA (Tan IIA), as a potential Aurora B kinase inhibitor. The in silico docking study indicates that Tan IIA docks into the ATP-binding pocket of Aurora B, which is further confirmed by in vitro kinase assay, ex vivo pull-down, and ATP competitive binding assay. Tan IIA exhibited a significant anti-tumor effect on OSCC cells both in vitro and in vivo, i
SUBMITTER: Li M
PROVIDER: S-EPMC7862432 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA